MOTT DAVID M (CIK 1219871) reported 15 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-23). Recent activity: Buy NVAX (18,880 shares), Buy ARDX (20,282 shares), Buy ARDX (26,455 shares), Buy ARDX (333,333 shares), Sell MRSN (23,546 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | NOVAVAX INC (NVAX) | Director | Buy | 18,880 | $0 |
| 2026-06-18 | ARDELYX, INC. (ARDX) | Director | Buy | 20,282 | $0 |
| 2026-06-18 | ARDELYX, INC. (ARDX) | Director | Buy | 26,455 | $0 |
| 2026-02-23 | ARDELYX, INC. (ARDX) | Director | Buy | 333,333 | $1.9M |
| 2026-01-06 | Mersana Therapeutics, Inc. (MRSN) | Director | Sell | 23,546 | $0 |
| 2026-01-06 | Mersana Therapeutics, Inc. (MRSN) | Director | Sell | 383 | $0 |
| 2025-06-23 | ARDELYX, INC. (ARDX) | Director | Buy | 31,163 | $0 |
| 2025-06-23 | ARDELYX, INC. (ARDX) | Director | Buy | 41,551 | $0 |
| 2025-06-18 | ARDELYX, INC. (ARDX) | Director | Buy | 200,000 | $726,000 |
| 2025-06-13 | NOVAVAX INC (NVAX) | Director | Buy | 10,420 | $0 |
| 2025-06-11 | ARDELYX, INC. (ARDX) | Director | Buy | 200,000 | $738,000 |
| 2025-05-19 | ARDELYX, INC. (ARDX) | Director | Buy | 100,000 | $329,000 |
| 2025-05-05 | ARDELYX, INC. (ARDX) | Director | Buy | 381,377 | $1.6M |
| 2025-02-26 | ARDELYX, INC. (ARDX) | Director | Buy | 77,729 | $388,645 |
| 2025-01-22 | ARDELYX, INC. (ARDX) | Director | Buy | 199,000 | $993,010 |
Source: SEC Form 4 filings · as of 2026-06-23